Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05200208 · ClinicalTrials.gov registry record · NA

Improving Sleep and Cognition in Alzheimer's Disease

A NA study of Alzheimer Disease, sponsored by Emory University.

Completed
Registry status
NA
Development phase
20
Enrollment target
2
Study locations

NCT05200208 is a NA study of Alzheimer Disease that has completed, run by Emory University. The registered enrollment target is 20 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05200208, a NA study of Alzheimer Disease, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

Cognitive disorders include such things as memory disorders, mild cognitive impairment, and Alzheimer's disease (AD). The purpose of the study is to learn more about whether a dietary citicoline supplement will improve sleep and cognition. Sleep disturbances currently afflict approximately 25-44% of those with AD, resulting in decreased quality of life for those with AD and their caregivers and are a major driver of institutionalization. Previous studies have tested this dietary supplement in Alzheimer's disease and shown that citicoline may improve cognitive decline. The research team would like to see if citicoline will also improve sleep. The citicoline that will be provided is made by Kyowa Hakko Pharma Chemical Company. This dietary supplement has been tested for Alzheimer's disease and found to be well tolerated. Citicoline has previously been used safely in other Alzheimer's disease populations at the same dosage.

Conditions Studied

Alzheimer Disease

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Citicoline supplement

Study Locations (2)

Georgia

  • Emory University School of Nursing - Atlanta
  • Goizueta Alzheimer's Disease Research Center - Atlanta

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-07-27
Est. Completion 2025-09-21
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05200208

The ClinicalTrials.gov registry entry for NCT05200208 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05200208 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05200208 about?

NCT05200208 is a clinical study titled "Improving Sleep and Cognition in Alzheimer's Disease". Cognitive disorders include such things as memory disorders, mild cognitive impairment, and Alzheimer's disease (AD). The purpose of the study is to learn more about whether a dietary citicoline supplement will improve sleep and cognition. Sleep disturbances currently afflict approximately 25-44% of...

What is the current status of trial NCT05200208?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-07-27. Estimated completion is 2025-09-21.

What conditions does trial NCT05200208 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT05200208?

The interventions under investigation include: Placebo (OTHER), Citicoline supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05200208?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05200208 being conducted?

This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.